Clinical Trial Update: Minimal Residual Disease in Peripheral T-cell Lymphoma

View source ↗

Summary

This clinical trials update reports on minimal residual disease in peripheral T-cell lymphoma; the study has completed and is sponsored by Washington University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Peripheral T Cell Lymphoma | Status: COMPLETED